Navin Fluorine International Limited · NSE:NAVINFLUOR
Navin Fluorine International — Q2 FY2026 Earnings Presentation
32 slides from Navin Fluorine International's earnings presentation, Oct 30, 2025
Slide 1: Exchange intimation letter for Investor Presentation Q2 & H1 FY26
October 30, 2025 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Dalal Street, Fort, Bandra Kurla Complex, Bandra (East), Mumbai 400001 Mumbai 400051 Scrip Code: 532504 Symbol: NAVINFLUOR Dear Sir / Madam, Sub.: Investor Presentation for Q2 & H1 of Fin
Slide 2: Advancing With Purpose - Investor Presentation October 2025
Advancing With Purpose Investor Presentation - October 2025
Slide 3: Safe Harbor
Safe Harbor This presentation and the accompanying slides (the “Presentation”), which have been prepared by Navin Fluorine International Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe
Slide 4: Q2 & H1 FY26 Financial Performance
Q2 & H1 FY26 Financial Performance
Slide 5: Q2FY26 - Performance at a glance
Q2FY26 - Performance at a glance Sales Operating EBITDA Operating EBITDA Margin Operating PBT Rs. 758.4 Crs Rs. 246.2 Crs 32.5% Rs. 179.3 Crs Q2FY26 + 46% Y-o-Y + 129% Y-o-Y + 1176 bps Y-o-Y + 173% Y-o-Y + 5% Q-o-Q + 19% Q-o-Q + 395 bps Q-o-Q + 27% Q-o-Q Revenue Growth (Y-o-Y) HPP Specialty CDMO 38%
Slide 6: H1FY26 - Performance at a glance
H1FY26 - Performance at a glance Sales Operating EBITDA Operating EBITDA Margin Operating PBT Rs. 1483.8 Crs Rs. 453.0 Crs 30.5% Rs. 320.5 Crs H1 FY26 + 42% Y-o-Y + 118% Y-o-Y + 1060 bps Y-o-Y + 159% Y-o-Y Revenue Growth (Y-o-Y) HPP Specialty CDMO 41% 37% 57% Consolidated Financials 5
Slide 7: Capex Announcements
Capex Announcements HFC MPP Additional HFC capacity equivalent upto 15,000 MTPA of De-bottlenecking MPP capacity at Dahej to support Capex Details R32 launch of new molecule for a global innovator • Strong projections received from global innovator to Constructive global demand-supply environment dr
Slide 8: Business Vertical - HPP
Business Vertical - HPP Revenues Q2FY26 Highlights Rs. crores +38% 404 293 ✓ Revenue growth led by higher realizations and volumes in both domestic and well as international markets ✓ For R32, both the plants are running at optimal capacity Q2 FY25 Q2 FY26 AHF capex : Mechanical trials underway, com
Slide 9: Business Vertical - Specialty Chemicals
Business Vertical - Specialty Chemicals Revenues Q2FY26 Highlights Rs. crores +39% 220 158 ✓ Strong outlook for H2 backed by purchase orders ✓ Fluro specialty plant has started contributing meaningfully from this quarter Q2 FY25 Q2 FY26 ✓ Chemours project is on track for completion in Q1FY27 ✓ De-bo
Slide 10: Business Vertical - CDMO
Business Vertical - CDMO Revenues Q2FY26 Highlights Rs. crores +98% 134 ✓ Order book pipeline till FY27 backed by purchase orders 68 ✓ European CDMO MSA : • Validation batches started in cGMP4, supplies targeted by Jan 26 Q2 FY25 Q2 FY26 • Strong outlook with 3 years projection 4% ✓ Strategy -in-act
Slide 11: Consolidated Profitability Statement
Consolidated Profitability Statement Y-o-Y Q-o-Q Y-o-Y Particulars (Rs. Crs) Q2 FY26 Q2 FY25 Q1 FY26 H1 FY26 H1 FY25 Change % Change % Change % Net Revenue From Operations 758.42 518.56 46.26% 725.40 4.55% 1,483.82 1,042.24 42.37% Raw Material 312.90 223.98 307.71 620.61 454.37 Employee Expenses 73.
Slide 12: Consolidated Balance Sheet Statement
Consolidated Balance Sheet Statement Particulars (Rs. Crs) Sep’25 Mar’25 Particulars (Rs. Crs) Sep’25 Mar’25 ASSETS EQUITY Non-Current Assets (a) Equity share capital 10.25 9.92 Property, plant and equipment 2,579.33 2,550.47 (b) Other equity Right-of-use assets 53.14 46.27 (i) Reserves & Surplus 3,
Slide 13: Consolidated Cash Flow Statement
Consolidated Cash Flow Statement Cash Flow Statement (Rs. Crs.) H1 FY26 H1 FY25 Cash Flow from Operating Activities Profit before Tax 352.61 145.05 Adjustment for Non-Operating Items 102.75 78.07 Operating Profit before Working Capital Changes 455.36 223.12 Changes in Working Capital (108.69) 29.49
Slide 14: Standalone Profitability Statement
Standalone Profitability Statement Y-o-Y Q-o-Q Y-o-Y Particulars (Rs. Crs.) Q2 FY26 Q2 FY25 Q1 FY26 H1 FY26 H1 FY25 Change % Change % Change % Net Revenue From Operations 562.37 385.82 45.76% 542.95 3.58% 1,105.32 762.10 45.04% Raw Material 251.08 174.89 239.44 490.52 346.02 Employee Expenses 52.61
Slide 15: Standalone Balance Sheet Statement
Standalone Balance Sheet Statement Particulars (Rs. Crs.) Sep’25 Mar’25 Particulars (Rs. Crs) Sep’25 Mar’25 ASSETS EQUITY Non-Current Assets (a) Equity share capital 10.25 9.92 Property, plant and equipment 725.48 721.09 (b) Other equity (i) Reserves & Surplus 3,290.00 2,336.41 Right-of-use assets 2
Slide 16: Standalone Cash Flow Statement
Standalone Cash Flow Statement Cash Flow Statement (Rs. Crs.) H1 FY26 H1 FY25 Cash Flow from Operating Activities Profit before Tax 325.98 132.03 Adjustment for Non-Operating Items 0.41 20.20 Operating Profit before Working Capital Changes 326.39 152.23 Changes in Working Capital (75.34) (67.19) Cas
Slide 17: Company Overview
Company Overview
Slide 18: Resilient business model: diversified divisions, products, plants & end markets
Resilient business model: 3 4 900+ diversified divisions, Geographies Factories Total Customers products, plants & end 4 Countries 3 R&D Centres 1,498 Total Employees markets 3 5 Business Verticals Sales Offices Preferred source and a partner of choice for diverse fluorochemical solutions globally L
Slide 19: 3P approach to building capacities, platforms and long-term partnerships
3P approach to building Diverse portfolio including fluorine- capacities, building scalable based intermediates, specialty chemicals and inorganic chemicals platforms and nurturing long- term partnerships Product 3P FOCUS Forging multiyear partnerships to Partnerships Focus on owning specific integr
Slide 20: Trusted to deliver, where IP integrity meets excellence and performance
Trusted to deliver, where IP Robust R&D engagement supports integrity meets excellence and Strong partnership with Global co-development initiatives, Innovators across diverse accelerating innovation & performance segments customised solutions Agile manufacturing Swift absorption of new infrastructu
Slide 21: Navin Fluorine: Precision in chemistry, purpose in execution
Navin Fluorine: Precision in One-Stop Fluorine provider, with the Group serving Prominent brand symbolising market Rich experience, with decades of operational chemistry, purpose in diverse customer needs, from gramscale to multi- leadership, service reliability, manufacturing expertise, the Group i
Slide 22: Strong R&D to manage diversified portfolios, from ideation to commercialization
Strong R&D to manage diversified KEY R&D HIGHLIGHTS FY25 portfolios, from ideation to Driving research-based culture to develop complex KSMs for global pharma and biotech commercialization of molecules innovators Backward integration into high end fluorine Navin Research & Innovation Navin Molecular
Slide 23: Enhancing our agility, resilience and competitiveness to foster sustainable progress
Enhancing our agility, resilience and competitiveness to foster sustainable progress Reputed Brand Mafron Rich Legacy Integrated Fluorine Strategic Committed to ESG Diversified Portfolio Prominent Clientele Provider Partnerships World-class Credible Strong Global Thriving Workforce Infrastructure Ce
Slide 24: Leading with ESG in Action
Leading with ESG in Action
Slide 25: Environmentally friendly initiatives across our facilities in FY25
We undertook various environmentally friendly initiatives across our facilities in FY25 SURAT DEWAS DAHEJ • Reduction of 1,66,352 SCM of natural gas using waste heat from flue gas in the HF plant • Increased solar electricity capacity from 1 MW • Condensate recovery from CPP, MEE, Orchid, to 2.2 MW
Slide 26: Progress and impact of our environmental initiatives
Progress and impact of our environmental initiatives All three sites of Navin Fluorine conferred with 8th Annual HSE Strategy Summit & Awards 2025 for 'Commitment to Environmental Excellence Greentech PCWR Excellence - 2024 Award for Pollution We are a Responsible Care Control, Waste Management & Re
Slide 27: Board demographics and independence
Board Demographics Meetings Board Independence during Highly FY 2025 engaged 5 of 9 Board 15 55% Directors are actively involved in NFIL’s Board Committee Independent strategic transformation 58 years median Directors’ age 8 Highly Experienced Board Board to chair Committees 78% 7 of 9 Directors are
Slide 28: Practices, regulations and protocols set by our board of directors
Reflects the practices, regulations and Composition of the Statutory protocols set by our board of directors Committees as on March 31, 2025 Structured policies and processes addressed Out of 4 Members of the Audit Committee, 3 investor grievances are Independent and 1 Non-Executive Reported NO Acce
Slide 29: Diversity of thought and experience
Diversity of thought and experience Mr. Vishad P. Mafatlal (Chairman) Ms. Apurva S. Purohit (Independent Director) He is an industrialist having varied experience of over 28+ Years in the field of Textiles and She is a prominent Indian Business leader with over 32 years of experience in the media an
Slide 30: Investing in community well-being
Investing in community well-being CSR contribution made to: SHRI SADGURU SEVA ACT-EVE FOUNDATION SANGH TRUST Total CSR expenditure for FY25 Rs. 7.95 Crores CHARUTAR AROGYA MANDAL SHALA PRAVESHOTSAV BLIND PEOPLE’S CANCER PATIENT AID ASSOCIATION ASSOCIATION FOUNDATION FOR KC MAHINDRA PROMOTION OF SPOR
Slide 31: Track record of progressive dividends
Track record of progressive dividends Dividend as % of Face Value Special Final Interim Payout %* 750% 750% 150% 600% 600% 550% 550% 550% 500% 150% 600% 150% 390 350% 350% 350% 300% 300% 315% 325% 75% 200% 180% 210% 160% 160% 400% 140% 150% 150% 130% 110% 85% 65% 75% 85% 85% 250% 250% 250% 250% 250%
Slide 32: For further information, please contact
For further information, please contact: Navin Fluorine International Ltd. CIN : L24110MH1998PLC115499 Mr. Anish Ganatra Chief Financial Officer anish.ganatra@nfil.in anish.ganatra@nfil.in www.nfil.in www.nfil.in Investor Relations Advisors: MUFG Intime India Private Limited A part of MUFG Corporate
Navin Fluorine International — Q2 FY2026 Earnings Presentation on 6ix